Dr Platz is an internationally experienced German-born surgeon and academic.
Based in Hamilton, New Zealand, Platz currently works as a surgical registrar and colorectal fellow at the Department of Surgery of Waikato Hospital.
Platz completed a ‘Summa cum Laude’ level Doctoral Thesis at Albert Ludwig University in Freiburg, Germany, which is the highest educational level of distinction an academic can receive.
He also received the Goedecke Research Award during his time at the university, in recognition of his outstanding experimental work.
In Wisconsin, USA, Platz was instrumental in launching the immunosuppressive drug CellCept (Mycophenolate Mofetil), which is widely used to prevent the body from rejecting a kidney, liver, or heart transplant today.
In his postdoctoral thesis, completed at Humboldt University of Berlin, Platz investigated the value of measuring cytokine molecules following clinical liver transplantation.
He highlighted the value of some cytokines like IL-6 and IL-8 in predicting postoperative complications and infections, both of which are still under investigation.
Platz also established the pancreas transplant programme in Berlin, as he had not only done experimental pancreas and kidney transplantation in Wisconsin, but was also involved in the clinical programme.
He then helped to set up the living related kidney transplant programme in Kiel, as well as the combined pancreas/kidney transplant programme, and was involved in the establishment of the small bowel transplant programme both there and in Berlin.
Klaus Platz’s specialities include oncologic, laparoscopic, thoracic, hepatobiliary, cardiovascular and transplantation surgeries, which he has performed for teaching purposes and independently.
See details of some of Klaus Platz‘s peer reviewed publications on Biomedexperts.com.